Your search for ganciclovir returned 3 results

Viracta Therapeutics announced that the FDA has granted Orphan Drug designation to nanatinostat (VRx-3996), in combination with valganciclovir, for the treatment of post-transplant lymphoproliferative disorder.

Cytovene-IV is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor.

The Food and Drug Administration (FDA) has approved labeling updates for Valcyte (valganciclovir; Roche) tablets and oral solution to include expanded pediatric indication and dosage sections.